narcolepsy drugs

Molly Ferguson for STAT Several major biotech players are racing to develop a new class of narcolepsy drugs known as orexin receptor agonists, with potentially major ramifications not only for treating sleep disorders but also for a broader class of conditions that lead people to experience fatigue during the day, like Alzheimer’s and depression. Companies working […]